Prognostic Subgroups for Remission, Response, and Treatment Continuation
in the Clinical Antipsychotic Trials of Intervention Effectiveness
Many patients with schizophrenia
continue to have debilitating negative symptoms, cognitive deficits, and
side effects. The authors of this study set out to determine which factors
moderate outcomes of treatment with antipsychotics. Find out what they were
able to determine from a secondary analysis of the CATIE trial.
>> See entire article